Patent holdings for IPC class C07D 281/10

Total number of patents in this class: 144

10-year publication summary

17
6
2
11
11
17
22
12
9
3
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Albireo AB
169
32
Elobix AB
17
15
Armgo Pharma, Inc.
15
10
Glaxosmithkline Intellectual Property (no.2) Limited
288
9
Glaxosmithkline Intellectual Property Development Limited
760
7
RyCarma Therapeutics, Inc.
21
7
Shire Human Genetic Therapies, Inc.
190
5
VALO Health, Inc.
172
3
Novartis AG
10867
2
Glaxosmithkline LLC
537
2
Merck Sharp & Dohme Corp.
2200
2
Sanofi-Aventis Deutschland GmbH
2630
2
Apeiron Biologics AG
32
2
Assembly Biosciences, Inc.
76
2
KYORIN Pharmaceutical Co., Ltd.
168
2
Les Laboratoires Servier
544
2
Shanghai Institute of Pharmaceutical Industry
129
2
HK Inno.n Corporation
106
2
Shanghai Zhongze Therapeutics, Co. Ltd.
5
2
Hainan Jin Rui Pharmaceutical Co., Ltd.
8
2
Other owners 32